Experimental models of hepatic encephalopathy: ISHEN guidelines

Roger F. Butterworth, Michael D Norenberg, Vicente Felipo, Peter Ferenci, Jan Albrecht, Andres T. Blei

Research output: Contribution to journalArticle

183 Citations (Scopus)

Abstract

Objectives of the International Society for Hepatic Encephalopathy and Nitrogen Metabolism Commission were to identify well-characterized animal models of hepatic encephalopathy (HE) and to highlight areas of animal modelling of the disorder that are in need of development. Features essential to HE modelling were identified. The best-characterized animal models of HE in acute liver failure, the so-called Type A HE, were found to be the hepatic devascularized rat and the rat with thioacetamide-induced toxic liver injury. In case of chronic liver failure, surgical models in the rat involving end-to-side portacaval anastomosis or bile duct ligation were considered to best model minimal/mild (Type B) HE. Unfortunately, at this time, there are no satisfactory animal models of Type C HE resulting from end-stage alcoholic liver disease or viral hepatitis, the most common aetiologies encountered in patients. The commission highlighted the urgent need for such models and of improved models of HE in chronic liver failure in general as well as a need for models of post-transplant neuropsychiatric disorders. Studies of HE pathophysiology at the cellular and molecular level continue to benefit from in vitro and or ex vivo models involving brain slices or exposure of cultured cells (principally cultured astrocytes) to toxins such as ammonia, manganese and pro-inflammatory cytokines. More attention could be paid in the future to in vitro models involving the neurovascular unit, microglia and neuronal co-cultures in relation to HE pathogenesis.

Original languageEnglish
Pages (from-to)783-788
Number of pages6
JournalLiver International
Volume29
Issue number6
DOIs
StatePublished - Jun 19 2009

Fingerprint

Hepatic Encephalopathy
Theoretical Models
Guidelines
End Stage Liver Disease
Animal Models
Thioacetamide
Surgical Portacaval Shunt
Anatomic Models
Alcoholic Liver Diseases
Acute Liver Failure
Poisons
Liver
Microglia
Manganese
Coculture Techniques
Bile Ducts
Ammonia
Astrocytes
Hepatitis
Ligation

Keywords

  • Acute liver failure
  • Ammonia
  • Animal models
  • Astrocytes
  • Azoxymethane
  • Bile duct ligation
  • Cirrhosis
  • Galactosamine
  • Hepatic encephalopathy
  • Portacaval anastomosis
  • Thioacetamide

ASJC Scopus subject areas

  • Hepatology

Cite this

Butterworth, R. F., Norenberg, M. D., Felipo, V., Ferenci, P., Albrecht, J., & Blei, A. T. (2009). Experimental models of hepatic encephalopathy: ISHEN guidelines. Liver International, 29(6), 783-788. https://doi.org/10.1111/j.1478-3231.2009.02034.x

Experimental models of hepatic encephalopathy : ISHEN guidelines. / Butterworth, Roger F.; Norenberg, Michael D; Felipo, Vicente; Ferenci, Peter; Albrecht, Jan; Blei, Andres T.

In: Liver International, Vol. 29, No. 6, 19.06.2009, p. 783-788.

Research output: Contribution to journalArticle

Butterworth, RF, Norenberg, MD, Felipo, V, Ferenci, P, Albrecht, J & Blei, AT 2009, 'Experimental models of hepatic encephalopathy: ISHEN guidelines', Liver International, vol. 29, no. 6, pp. 783-788. https://doi.org/10.1111/j.1478-3231.2009.02034.x
Butterworth, Roger F. ; Norenberg, Michael D ; Felipo, Vicente ; Ferenci, Peter ; Albrecht, Jan ; Blei, Andres T. / Experimental models of hepatic encephalopathy : ISHEN guidelines. In: Liver International. 2009 ; Vol. 29, No. 6. pp. 783-788.
@article{579d3105047d4e49b4986975e3cbdfe9,
title = "Experimental models of hepatic encephalopathy: ISHEN guidelines",
abstract = "Objectives of the International Society for Hepatic Encephalopathy and Nitrogen Metabolism Commission were to identify well-characterized animal models of hepatic encephalopathy (HE) and to highlight areas of animal modelling of the disorder that are in need of development. Features essential to HE modelling were identified. The best-characterized animal models of HE in acute liver failure, the so-called Type A HE, were found to be the hepatic devascularized rat and the rat with thioacetamide-induced toxic liver injury. In case of chronic liver failure, surgical models in the rat involving end-to-side portacaval anastomosis or bile duct ligation were considered to best model minimal/mild (Type B) HE. Unfortunately, at this time, there are no satisfactory animal models of Type C HE resulting from end-stage alcoholic liver disease or viral hepatitis, the most common aetiologies encountered in patients. The commission highlighted the urgent need for such models and of improved models of HE in chronic liver failure in general as well as a need for models of post-transplant neuropsychiatric disorders. Studies of HE pathophysiology at the cellular and molecular level continue to benefit from in vitro and or ex vivo models involving brain slices or exposure of cultured cells (principally cultured astrocytes) to toxins such as ammonia, manganese and pro-inflammatory cytokines. More attention could be paid in the future to in vitro models involving the neurovascular unit, microglia and neuronal co-cultures in relation to HE pathogenesis.",
keywords = "Acute liver failure, Ammonia, Animal models, Astrocytes, Azoxymethane, Bile duct ligation, Cirrhosis, Galactosamine, Hepatic encephalopathy, Portacaval anastomosis, Thioacetamide",
author = "Butterworth, {Roger F.} and Norenberg, {Michael D} and Vicente Felipo and Peter Ferenci and Jan Albrecht and Blei, {Andres T.}",
year = "2009",
month = "6",
day = "19",
doi = "10.1111/j.1478-3231.2009.02034.x",
language = "English",
volume = "29",
pages = "783--788",
journal = "Liver International",
issn = "1478-3223",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Experimental models of hepatic encephalopathy

T2 - ISHEN guidelines

AU - Butterworth, Roger F.

AU - Norenberg, Michael D

AU - Felipo, Vicente

AU - Ferenci, Peter

AU - Albrecht, Jan

AU - Blei, Andres T.

PY - 2009/6/19

Y1 - 2009/6/19

N2 - Objectives of the International Society for Hepatic Encephalopathy and Nitrogen Metabolism Commission were to identify well-characterized animal models of hepatic encephalopathy (HE) and to highlight areas of animal modelling of the disorder that are in need of development. Features essential to HE modelling were identified. The best-characterized animal models of HE in acute liver failure, the so-called Type A HE, were found to be the hepatic devascularized rat and the rat with thioacetamide-induced toxic liver injury. In case of chronic liver failure, surgical models in the rat involving end-to-side portacaval anastomosis or bile duct ligation were considered to best model minimal/mild (Type B) HE. Unfortunately, at this time, there are no satisfactory animal models of Type C HE resulting from end-stage alcoholic liver disease or viral hepatitis, the most common aetiologies encountered in patients. The commission highlighted the urgent need for such models and of improved models of HE in chronic liver failure in general as well as a need for models of post-transplant neuropsychiatric disorders. Studies of HE pathophysiology at the cellular and molecular level continue to benefit from in vitro and or ex vivo models involving brain slices or exposure of cultured cells (principally cultured astrocytes) to toxins such as ammonia, manganese and pro-inflammatory cytokines. More attention could be paid in the future to in vitro models involving the neurovascular unit, microglia and neuronal co-cultures in relation to HE pathogenesis.

AB - Objectives of the International Society for Hepatic Encephalopathy and Nitrogen Metabolism Commission were to identify well-characterized animal models of hepatic encephalopathy (HE) and to highlight areas of animal modelling of the disorder that are in need of development. Features essential to HE modelling were identified. The best-characterized animal models of HE in acute liver failure, the so-called Type A HE, were found to be the hepatic devascularized rat and the rat with thioacetamide-induced toxic liver injury. In case of chronic liver failure, surgical models in the rat involving end-to-side portacaval anastomosis or bile duct ligation were considered to best model minimal/mild (Type B) HE. Unfortunately, at this time, there are no satisfactory animal models of Type C HE resulting from end-stage alcoholic liver disease or viral hepatitis, the most common aetiologies encountered in patients. The commission highlighted the urgent need for such models and of improved models of HE in chronic liver failure in general as well as a need for models of post-transplant neuropsychiatric disorders. Studies of HE pathophysiology at the cellular and molecular level continue to benefit from in vitro and or ex vivo models involving brain slices or exposure of cultured cells (principally cultured astrocytes) to toxins such as ammonia, manganese and pro-inflammatory cytokines. More attention could be paid in the future to in vitro models involving the neurovascular unit, microglia and neuronal co-cultures in relation to HE pathogenesis.

KW - Acute liver failure

KW - Ammonia

KW - Animal models

KW - Astrocytes

KW - Azoxymethane

KW - Bile duct ligation

KW - Cirrhosis

KW - Galactosamine

KW - Hepatic encephalopathy

KW - Portacaval anastomosis

KW - Thioacetamide

UR - http://www.scopus.com/inward/record.url?scp=67149146685&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67149146685&partnerID=8YFLogxK

U2 - 10.1111/j.1478-3231.2009.02034.x

DO - 10.1111/j.1478-3231.2009.02034.x

M3 - Article

C2 - 19638106

AN - SCOPUS:67149146685

VL - 29

SP - 783

EP - 788

JO - Liver International

JF - Liver International

SN - 1478-3223

IS - 6

ER -